Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?

Oncotarget. 2021 May 25;12(11):1032-1036. doi: 10.18632/oncotarget.27931. eCollection 2021 May 25.NO ABSTRACTPMID:34084277 | PMC:PMC8169070 | DOI:10.18632/oncotarget.27931
Source: Oncotarget - Category: Cancer & Oncology Authors: Source Type: research